General
Pfizer’s COVID vaccine success is worth an extra $14 billion to the US pharma giant
The success of its COVID vaccine, and the challenges faced by some of its rivals, look set to earn US pharmaceutical giant Pfizer at least an extra $US11 billion ($14.2 billion) in revenue this year.
Key points:
- Pfizer has raised its 2021 revenue forecasts for COVID vaccine sales by 73 per cent
- Click here to view the original article.
Continue Reading
-
General15 hours agoTasmanian woman drowns on day 5 of multi-day Franklin River rafting trip
-
Noosa News19 hours agoResilience features in Sunshine Coast Open House
-
Noosa News14 hours agoPerth Royal Show vendors upset by price hikes, say crowds are down in 2025
-
General8 hours agoCampers evacuated, residents on alert as Moreton Island bushfire intensifies